@article{dacc492e9ffd45bebeed2dcf31ff8c2f,
title = "A population-based overview of sequences of targeted therapy in Metastatic renal cell carcinoma",
author = "Nimira Alimohamed and Lee, {Jae Lyn} and Sandy Srinivas and Bjarnason, {Georg A.} and Knox, {Jennifer J.} and Mackenzie, {Mary J.} and Lori Wood and Vaishampayan, {Ulka N.} and Tan, {Min Han} and Rha, {Sun Young} and Frede Donskov and Srinivas Tantravahi and Christian Kollmannsberger and Scott North and Rini, {Brian I.} and Choueiri, {Toni K.} and Heng, {Daniel Y.C.}",
note = "Funding Information: Jae-Lyn Lee has received honoraria from Novartis, Bayer, and Pfizer; has received research funding from Bayer. Georg A. Bjarnason has been a consultant and played an advisory role at Pfizer and received honoraria and research funding from Pfizer. Jennifer J. Knox has been a consultant and played an advisory role at Aveo and has received research funding from Pfizer. Mary J. MacKenzie has an advisory role and has received funding from Novartis and Pfizer. Lori Wood has an advisory role at Pfizer and Novartis and has received research funding from Pfizer, Novartis, and GlaxoSmithKline. Ulka N. Vaishampayan has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. Sun Young Rha has an advisory role at Novartis, Pfizer, and GlaxoSmithKline and has received research funding from Novartis and Bayer Korea. Frede Donskov has received research funding from Novartis. Christian Kollmannsberger has an advisory role and has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. Scott North has an advisory role at Novartis, Bayer, GlaxoSmithKline, and Pfizer. Brian I. Rini has an advisory role at Pfizer, GlaxoSmithKline, Aveo, Bayer, and Onyx and has received research funding from GlaxoSmithKline and Pfizer. Toni K. Choueiri has received research funding from Pfizer and has an advisory role at Aveo, Pfizer, Novartis, GlaxoSmithKline, Genentech, Bayer, and Onyx. Daniel Y.C. Heng has received research funding from Pfizer and has an advisory role at Pfizer, Novartis, GlaxoSmithKline, Aveo, Genentech, Bayer, and Onyx. All other authors state that they have no conflicts of interest.",
year = "2014",
month = aug,
doi = "10.1016/j.clgc.2013.12.003",
language = "English",
volume = "12",
pages = "e127--e131",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "4",
}
